These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice. Sun X; Yamada H; Shibata K; Muta H; Tani K; Podack ER; Yoshikai Y J Immunol; 2010 Aug; 185(4):2222-30. PubMed ID: 20639486 [TBL] [Abstract][Full Text] [Related]
4. IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model. Akiyama K; Karaki M; Kobayshi R; Dobashi H; Ishida T; Mori N Int Arch Allergy Immunol; 2009; 149(4):315-22. PubMed ID: 19295235 [TBL] [Abstract][Full Text] [Related]
5. An essential role for dendritic cells in human and experimental allergic rhinitis. KleinJan A; Willart M; van Rijt LS; Braunstahl GJ; Leman K; Jung S; Hoogsteden HC; Lambrecht BN J Allergy Clin Immunol; 2006 Nov; 118(5):1117-25. PubMed ID: 17088138 [TBL] [Abstract][Full Text] [Related]
6. Amelioration of experimental allergic rhinitis with suppression of topical immune responses by lack of IL-27/WSX-1 signaling. Shimanoe Y; Miyazaki Y; Hara H; Inokuchi A; Yoshida H Ann Allergy Asthma Immunol; 2009 Mar; 102(3):223-32. PubMed ID: 19354069 [TBL] [Abstract][Full Text] [Related]
7. Direct evidence for a critical role of CD30 in the development of allergic asthma. Polte T; Behrendt AK; Hansen G J Allergy Clin Immunol; 2006 Oct; 118(4):942-8. PubMed ID: 17030250 [TBL] [Abstract][Full Text] [Related]
8. United airways: circulating Th2 effector cells in an allergic rhinitis model are responsible for promoting lower airways inflammation. KleinJan A; Willart M; van Nimwegen M; Leman K; Hoogsteden HC; Hendriks RW; Lambrecht BN Clin Exp Allergy; 2010 Mar; 40(3):494-504. PubMed ID: 19968652 [TBL] [Abstract][Full Text] [Related]
9. Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis. Won TB; Quan SH; Kim DY; Rhee CS; Lee CH Ann Allergy Asthma Immunol; 2009 Apr; 102(4):314-22. PubMed ID: 19441603 [TBL] [Abstract][Full Text] [Related]
10. Existence of antigen-specific immunoglobulin E is not sufficient for allergic nasal eosinophil infiltration in mice. Nishimura T; Saeki M; Kaminuma O; Matsuoka K; Yonekawa H; Mori A; Hiroi T Int Arch Allergy Immunol; 2013; 161 Suppl 2():125-8. PubMed ID: 23711863 [TBL] [Abstract][Full Text] [Related]
11. Listeriolysin O derived from Listeria monocytogenes inhibits the effector phase of an experimental allergic rhinitis induced by ovalbumin in mice. Yamamoto K; Kawamura I; Tominaga T; Nomura T; Ito J; Mitsuyama M Clin Exp Immunol; 2006 Jun; 144(3):475-84. PubMed ID: 16734617 [TBL] [Abstract][Full Text] [Related]
12. Intranasal application of Epstein-Barr virus/lipoplex to abrogate eosinophillia in murine model of allergic rhinitis. Han DM; Zhou B; Wang T; Wang XD; Fan EZ Chin Med J (Engl); 2006 Jun; 119(12):991-7. PubMed ID: 16805982 [TBL] [Abstract][Full Text] [Related]
13. CD30 ligand is a target for a novel biological therapy against colitis associated with Th17 responses. Sun X; Yamada H; Shibata K; Muta H; Tani K; Podack ER; Iwakura Y; Yoshikai Y J Immunol; 2010 Dec; 185(12):7671-80. PubMed ID: 21068411 [TBL] [Abstract][Full Text] [Related]
14. CD30 ligand is a new therapeutic target for central nervous system autoimmunity. Shinoda K; Sun X; Oyamada A; Yamada H; Muta H; Podack ER; Kira J; Yoshikai Y J Autoimmun; 2015 Feb; 57():14-23. PubMed ID: 25533628 [TBL] [Abstract][Full Text] [Related]
15. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice. Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212 [TBL] [Abstract][Full Text] [Related]
16. Role of NOD1-mediated signals in a mouse model of allergic rhinitis. Shin JH; Kim SW; Park YS Otolaryngol Head Neck Surg; 2012 Dec; 147(6):1020-6. PubMed ID: 23032918 [TBL] [Abstract][Full Text] [Related]
17. Allergic rhinitis induced by intranasal sensitization and challenge with trimellitic anhydride but not with dinitrochlorobenzene or oxazolone in A/J mice. Farraj AK; Harkema JR; Kaminski NE Toxicol Sci; 2004 Jun; 79(2):315-25. PubMed ID: 15056815 [TBL] [Abstract][Full Text] [Related]
18. Lactate dehydrogenase-elevating virus infection at the sensitization and challenge phases reduces the development of delayed eosinophilic allergic rhinitis in BALB/c mice. Sasaki Y; Hayashi T; Hasegawa K Scand J Immunol; 2007 Dec; 66(6):628-35. PubMed ID: 17949409 [TBL] [Abstract][Full Text] [Related]
19. Implications of nasopharynx-associated lymphoid tissue (NALT) in the development of allergic responses in an allergic rhinitis mouse model. Kim DY; Fukuyama S; Nagatake T; Takamura K; Kong IG; Yokota Y; Lee CH; Kiyono H Allergy; 2012 Apr; 67(4):502-9. PubMed ID: 22257110 [TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effects of IL-23 and IL-17 in a mouse model of allergic rhinitis. Wang M; Zhang W; Shang J; Yang J; Zhang L; Bachert C Clin Exp Allergy; 2013 Aug; 43(8):956-66. PubMed ID: 23889249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]